MedPath

The effects of orally and intraduodenally administered pea protein on satiety parameters in vivo in lean and obese subjects.

Completed
Conditions
Obesitas
overweight
10003018
Registration Number
NL-OMON34022
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
24
Inclusion Criteria

• Male, non smoking
• Age between 18 and 65 years
• Body Mass Index between 20 and 37 kg/m2
• No medication that could interfere with the test results (e.g. glucose lowering medication)
• No history of intestinal illness
• Stable body weight over the last three months

Exclusion Criteria

• Age under 18 and over 65 years
• BMI under 20 and over 37 kg/m2
• Medication or disease that could interfere with the results of the study, to be judged by the responsible medical doctor
• Recent blood donation
• Intestinal illness at any time in the past

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>We will be looking at the secreted satiety hormones by the biops. We will be<br /><br>looking at CCK, GLP-1, and PYY. We will also look at the hunger and satiety<br /><br>ratings of the subjects</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath